Premium
Treatment of CD19‐positive mixed phenotype acute leukemia with blinatumomab
Author(s) -
El Chaer Firas,
Ali Omer M.,
Sausville Edward A.,
Law Jennie Y.,
Lee Seung Tae,
Duong Vu H.,
Baer Maria R.,
Koka Rima,
Singh Zeba N.,
Wong Jerry,
Yared Jean A.,
Griffiths Elizabeth A.,
Emadi Ashkan
Publication year - 2019
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25317
Subject(s) - blinatumomab , medicine , acute lymphocytic leukemia , immunology , myeloid , myeloid leukemia , leukemia , chemotherapy , oncology , b cell , cd19 , antigen , cancer research , antibody , lymphoblastic leukemia